| Literature DB >> 24950377 |
Stuart G Jarrett1, Erin M Wolf Horrell2, Perry A Christian3, Jillian C Vanover4, Mary C Boulanger5, Yue Zou6, John A D'Orazio7.
Abstract
The melanocortin 1 receptor (MC1R), which signals through cAMP, is a melanocytic transmembrane receptor involved in pigmentation, adaptive tanning, and melanoma resistance. We report MC1R-mediated or pharmacologically-induced cAMP signaling promotes nucleotide excision repair (NER) in a cAMP-dependent protein kinase A (PKA)-dependent manner. PKA directly phosphorylates ataxia telangiectasia and Rad3-related protein (ATR) at Ser435, which actively recruits the key NER protein xeroderma pigmentosum complementation group A (XPA) to sites of nuclear UV photodamage, accelerating clearance of UV-induced photolesions and reducing mutagenesis. Loss of Ser435 within ATR prevents PKA-mediated ATR phosphorylation, disrupts ATR-XPA binding, delays recruitment of XPA to UV-damaged DNA, and elevates UV-induced mutagenesis. This study mechanistically links cAMP-PKA signaling to NER and illustrates potential benefits of cAMP pharmacological rescue to reduce UV mutagenesis in MC1R-defective, melanoma-susceptible individuals.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24950377 PMCID: PMC4076709 DOI: 10.1016/j.molcel.2014.05.030
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328